News Hub

Real-time financial, economic, and global news with market-focused context and analysis.

Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.

  • BMW is a buy for a 180-day horizon, citing a strong product cycle, scaling EVs, and cost discipline.
  • MPLX offers a 7%+ distribution yield with mid-single-digit EBITDA growth potential and income cushioning downside.
  • Sandisk is a buy on AI infrastructure-driven revenue, high margins, and strong free cash flow after a pullback.
  • Antero Resources looks vulnerable; a mid-term short targets $32 from $39 if weather-driven gas strength fades.
  • X-Energy is a long-term buy for high-temperature reactor and TRISO fuel optionality, tied to milestones.
  • NVIDIA is a guidance-driven buy after upside guidance and AI revenue acceleration, with a $391 target.
  • Hold Tyra Biosciences ahead of the Sept 9 IR-NMIBC readout due to financing risk and a binary clinical event.

Latest Articles

TFSL: Ride the Regional Bank Recovery — A Mid-term Long Trade After an Earnings Pop and Loan Momentum

TFSL: Ride the Regional Bank Recovery — A Mid-term Long Trade After an Earnings Pop and Loan Momentum

TFS Financial (TFSL) looks set to benefit from steady loan growth, a hefty cash dividend and improving investor sentiment in regional banks. Valuation is reasonable on a price-to-book around 2.6 and the stock sits below its 52-week high, giving room for a mid-term rebound. I outline a precise entry, stop and target for a 45-trading-day swing trade …

Haemonetics Shares Rally After CSL Plasma Signs Non-Exclusive Supply Pact

Haemonetics Shares Rally After CSL Plasma Signs Non-Exclusive Supply Pact

Haemonetics Corporation saw its stock climb 16.3% after announcing a non-exclusive supply agreement with CSL Plasma Inc. Under the pact signed on August 14, 2026, CSL may deploy Haemonetics' NexSys PCS devices with Persona PLUS technology and acquire related disposables for U.S. plasma collection centers. The deal contains no minimum purchase commi…

GeneDx Recovery: Why OPKO's Diagnostics Unit May Have Turned the Corner

GeneDx Recovery: Why OPKO's Diagnostics Unit May Have Turned the Corner

OPKO (OPK) trades like a beaten-down biotech but carries a diagnostics franchise and a balance sheet that make a measured long position attractive. With a market cap near $1.02B, EV/sales ~1.8x, improving technicals and upcoming program milestones with Entera Bio, I prefer a long trade sized modestly for recovery upside while protecting against con…

Buy the Dip in STMicro: Tactical Long into a Sector Pullback

Buy the Dip in STMicro: Tactical Long into a Sector Pullback

STMicroelectronics (STM) has given back a large chunk of recent gains and is trading near $52.22 after a corrective stretch. The company still benefits from structural growth in automotive microcontrollers, power electronics for EVs, and sensors. With a market cap near $47.4B, positive free cash flow, and improving technical momentum, a disciplined…

Edgewise After Servier: A Funded Path to the Cardio Catalysts

Edgewise After Servier: A Funded Path to the Cardio Catalysts

Edgewise Therapeutics has moved from a pure binary biotech to a company with optionality: an announced licensing arrangement with Servier should provide non-dilutive capital that extends runway for EDG-7500 and sevasemten. The trade: go long around current levels to capture upside into upcoming pivotal catalysts while protecting against trial and r…

Commercial Metals: Rebuilding the Base — A Tactical Long on CMC

Commercial Metals: Rebuilding the Base — A Tactical Long on CMC

Commercial Metals Company (CMC) looks like a constructive swing trade today. The business is cash-generative, pays a reliable dividend, and is diversifying into precast concrete after a $675M acquisition. Valuation is reasonable with a P/E near 13.7 and EV/EBITDA around 13.5. Technicals are neutral; catalyst flow and improving free cash flow suppor…

Materion's Growing Order Book and Technical Setup Make a Mid-Term Buy

Materion's Growing Order Book and Technical Setup Make a Mid-Term Buy

Materion (MTRN) looks buyable at current levels after a pullback. The company sells specialized materials for electronics, aerospace and optics; recent wins in gold targets and precision coatings plus a healthy backlog support revenue growth. Valuation is rich versus historical norms but the trade offers a defined entry at $266.61 with a $300 targe…

Green Circle Decarbonize Technology Limited Announce Share Capital Increase and Share Capital Alteration

Green Circle Decarbonize Technology Limited Announce Share Capital Increase and Share Capital Alteration

Green Circle Decarbonize Technology Limited announced an effective increase in its authorized share capital from $50,000 to $5,000,000 and a restructuring of its share capital into Class A and Class B ordinary shares with different voting rights. The changes include re-designation of all ordinary shares, repurchase of certain Class A shares, and is…

Widespread Tech and Small-Cap Volatility Drives Sharp Moves in Market Caps

Widespread Tech and Small-Cap Volatility Drives Sharp Moves in Market Caps

Stocks across market-cap categories swung sharply on Tuesday, with several semiconductor and storage companies posting double-digit declines while a handful of small-cap names delivered strong gains. Major movers included Arm, SanDisk, Micron, Applied Materials and Marvell among the largest market-cap names, and Weave Communications, Duos Tech and …

Cerus (CERS): A Blood-Safety Underdog Worth a Mid-Term Spec

Cerus (CERS): A Blood-Safety Underdog Worth a Mid-Term Spec

Cerus operates the INTERCEPT blood-safety platform for platelets and plasma. At a market cap near $600M and trading comfortably off its 52-week low, CERS combines recurring revenue characteristics with a short-interest backdrop and improving technicals that make a focused long swing trade attractive. This is a tactical, mid-term (45 trading days) t…

Home Depot Q2 FY2026: Sequential Sales Momentum Signals Potential Turnaround, But Earnings Trend Remains a Headwind

Home Depot Q2 FY2026: Sequential Sales Momentum Signals Potential Turnaround, But Earnings Trend Remains a Headwind

Home Depot beat consensus in Q2 FY2026 with adjusted EPS of $4.92 versus $4.73 and revenue of $47.86 billion versus $47.23 billion. The most constructive development was sequential U.S. same-store sales acceleration from +0.5% in May to +2.2% in July, suggesting the trough of the cycle may be behind the company. Gross margin expanded in the quarter…

SMCI: Deep-Value AI Play — Growth Is Real, Rumors Are the Roadblock

SMCI: Deep-Value AI Play — Growth Is Real, Rumors Are the Roadblock

Super Micro (SMCI) just reported staggering top-line momentum and margin improvement tied to AI server demand, yet the stock trades at a valuation that discounts much of that growth. The trade: a long position sized for high volatility with a clear stop and a $60 target over a 180-trading-day horizon, accepting legal and financing risk as the prima…